{'output': [['Dermapharm', 'COMP', 'Plan', 'March IPO', 'EVENT'], ['Dermapharm', 'COMP', 'Operate_In', 'Germany', 'GPE'], ['Dermapharm', 'COMP', 'Value', '1 billion euros', 'ECON_INDICATOR'], ['Dermapharm', 'COMP', 'List', 'Frankfurt Stock Exchange', 'ORG'], ['Family Owner', 'ORG', 'Ask', 'Berenberg', 'ORG', 'Organize', 'IPO', 'EVENT'], ['Dermapharm', 'COMP', 'First Stock Market Listing', 'Germany', 'GPE', 'Year', '2018', 'TIME'], ['Dermapharm', 'COMP', 'Alongside', 'Siemens’s', 'COMP', 'Healthineers', 'UNIT', 'IPO', 'EVENT'], ['Dermapharm', 'COMP', 'Owned', 'Wilhelm Beier', 'PERSON'], ['Dermapharm', 'COMP', 'Make', 'Treatments', 'PRODUCT', 'Against', 'Skin Diseases', 'PRODUCT', 'Insect Bites', 'PRODUCT', 'Hair Loss', 'PRODUCT', 'Allergy Drugs', 'PRODUCT', 'Dietary Supplements', 'PRODUCT'], ['Dermapharm', 'COMP', 'Post', 'Earnings', 'ECON_INDICATOR', 'More', '100 million euros', 'ECON_INDICATOR', 'This Year', 'TIME'], ['Beier', 'PERSON', 'Cancel', 'Planned Sale', 'EVENT', 'Company', 'Dermapharm', 'COMP', 'Private Equity Group', 'ORG', '2016', 'TIME'], ['BC Partners', 'ORG', 'Nordic Capital', 'ORG', 'Vied', 'Take Control', 'Group', 'COMP', '2016', 'TIME'], ['Private Equity Group', 'ORG', 'View', 'Over-the-counter Drugs Portfolio', 'PRODUCT', 'Attractive', '2016', 'TIME'], ['Private Equity Group', 'ORG', 'Regard', 'Group’s Business', 'COMP', 'Parallel Trade', 'PRODUCT', 'Little Growth Potential', 'CONCEPT', '2016', 'TIME'], ['Healthcare Distribution Firms', 'COMP', 'Make Money', 'Re-labelling', 'PRODUCT', 'Re-importing', 'PRODUCT', 'Without', 'Explicit Consent', 'CONCEPT', 'Drugmaker', 'COMP', '2018', 'TIME']]}